Repetitive Immunization Breaks Tolerance to Type XVII Collagen and Leads to Bullous Pemphigoid in Mice
Open Access
- 1 August 2011
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 187 (3) , 1176-1183
Abstract
Bullous pemphigoid (BP) is a subepidermal autoimmune blistering disease of the elderly associated with considerable morbidity and mortality. As unspecific immunosuppressants are still the mainstay of BP therapy, several animal models, based on the passive transfer of autoantibodies or immune cells, have been developed to obtain a better understanding of the pathogenesis of BP and evaluate novel therapeutic interventions. We describe in this study an experimental model inducing BP by immunization of immunocompetent mice with a recombinant form of the immunodominant 15th noncollagenous domain of murine BP180 (type XVII collagen). The homologous noncollagenous 16A domain of human BP180 has previously been identified as an immunodominant region in human BP. Immunization of female SJL/J mice with the murine peptide led to clinical disease within 14 wk in 56% of mice. In contrast, none of the other strains developed blisters despite the presence of autoantibodies. The clinical disease manifested for at least 8 wk without further manipulation. This novel immunization-induced model reflects key immunopathological characteristics of human BP, including binding of complement-fixing autoantibodies along the dermal–epidermal junction, elevated total IgE serum levels, and infiltration of skin lesions with eosinophilic granulocytes. The use of immunocompetent mice and the induction of sustained clinical disease not requiring additional interventions make this immunization-induced mouse model most suitable to further explore the pathogenesis of BP and novel therapeutic interventions for this and other autoantibody-mediated diseases.Keywords
This publication has 41 references indexed in Scilit:
- The role of Fc gamma receptors polymorphisms in bullous pemphigoidJournal of the American Academy of Dermatology, 2010
- What’s new in bullous pemphigoidThe Journal of Dermatology, 2010
- A Novel Active Mouse Model for Bullous Pemphigoid Targeting Humanized Pathogenic AntigenThe Journal of Immunology, 2010
- A Novel Humanized Neonatal Autoimmune Blistering Skin Disease Model Induced by Maternally Transferred AntibodiesThe Journal of Immunology, 2009
- Genetic influence on immune phenotype revealed strain-specific variations in peripheral blood lineagesPhysiological Genomics, 2008
- Human Bullous Pemphigoid Antigen 2 Transgenic Skin Elicits Specific IgG in Wild-Type MiceJournal of Investigative Dermatology, 2007
- A Pathogenic Role for IgE in Autoimmunity: Bullous Pemphigoid IgE Reproduces the Early Phase of Lesion Development in Human Skin Grafted to nu/nu MiceJournal of Investigative Dermatology, 2007
- IgE Basement Membrane Zone Antibodies Induce Eosinophil Infiltration and Histological Blisters in Engrafted Human Skin on SCID MiceJournal of Investigative Dermatology, 2007
- Serum IgE antibodies bind to the epidermal side of the basement membrane zone splits in bullous pemphigoidBritish Journal of Dermatology, 1992
- IgG Subclasses of Intercellular and Basement Membrane Zone Antibodies: The Relationship to the Capability of Complement FixationJournal of Investigative Dermatology, 1989